ANGO vs WAT · rev $292.5M vs P/E 32, rev $1.65B
AngioDynamics Inc (ANGO) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
ANGO currently screens at market cap $378.5M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the ANGO and WAT stock pages for the full models.
Not investment advice.